Clinical Trial Update: Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine [Phase 1]

View source ↗

Summary

Phase 1 trial assessing adjuvant effect and route of administration on safety and immunogenicity of the NDV-3 vaccine; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candida Infections
• Staphylococcal Infections

Drugs mentioned

• NDV-3 vaccine (NDV-3 vaccine)

Snippet

Sponsor: NovaDigm Therapeutics, Inc. | Conditions: Staphylococcal Infections, Yeast Infections | Phase 1 | Status: COMPLETED | Results posted: 2020-03-04